Phosphoinositide 3-kinase
Full Form of PI3K
What is PI3K?
PI3K (Phosphoinositide 3-kinase) is a family of enzymes involved in cellular functions such as growth, proliferation, differentiation, motility, survival and intracellular trafficking. These enzymes phosphorylate the 3'-hydroxyl group of the inositol ring of phosphoinositides, generating second messengers like PIP3. In India, PI3K is a crucial topic in molecular biology and medical research, particularly in cancer biology, as dysregulation of the PI3K/AKT/mTOR pathway is implicated in many cancers. Researchers at Indian institutes such as the Tata Memorial Centre, IISc, and AIIMS study PI3K mutations and develop targeted therapies. The term is frequently encountered in academic curricula for MBBS, MSc Biotechnology, and PhD programs, and is a key area in competitive exams like CSIR-UGC NET, ICMR JRF, and NEET PG. Understanding PI3K signaling is essential for grasping mechanisms of targeted cancer drugs (e.g., alpelisib) and for interpreting clinical trial results. In Indian biotech and pharmaceutical sectors, PI3K inhibitors are being explored for treating breast cancer, hematological malignancies, and more. The use of PI3K in diagnostic immunohistochemistry (e.g., detecting PIK3CA mutations) is also growing. Overall, PI3K remains a foundational concept in modern biomedical science with direct translational relevance in Indian healthcare.
PI3K का फुल फॉर्म
फॉस्फोइनोसाइटाइड 3-काइनेज
Example
The pathologist recommended a genomic test for PIK3CA mutations, as the PI3K pathway is often hyperactivated in Indian breast cancer patients.